SCHEMBL4973124

SCHEMBL4973124

CNC(=O)CCC[C@@](O)(c1cccc(Cl)c1)[C@@H]1CCCN(C(C)(C)C)C1

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3611839 0.85 REN (0.56) REN
SCHEMBL3611838 0.85 REN (0.56) REN
SCHEMBL4970928 0.84 REN (0.46) REN
SCHEMBL3614364 0.82 REN (0.62) REN
SCHEMBL3605969 0.81 REN (0.45) REN
SCHEMBL3605975 0.81 REN (0.45) REN
SCHEMBL4972346 0.78 REN (0.47) REN
SCHEMBL3601633 0.78 REN (0.85) REN
SCHEMBL3601630 0.78 REN (0.85) REN
SCHEMBL3617332 0.78 REN (0.85) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed